Efficacy and Safety (Including 24-hour Holter Monitoring) of Tiotropium Inhalation Capsules in Patients With COPD

NCT00239460 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

196

Enrollment

INDUSTRY

Sponsor class

Conditions

Pulmonary Disease, Chronic Obstructive

Interventions

DRUG: Tiotropium

Sponsor

Boehringer Ingelheim